Search for Clinical Trial Results
Cerebral Astrocytoma, Childhood - 25 Studies Found
Status | Study |
Completed |
Study Name: Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma Condition:
|
Terminated |
Study Name: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Condition:
|
Completed |
Study Name: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Condition:
|
Completed |
Study Name: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Condition:
|
Completed |
Study Name: ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors Condition:
|
Recruiting |
Study Name: Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Condition:
|
Completed |
Study Name: Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy Condition:
Date: 2008-05-14 Interventions: |
Active, not recruiting |
Study Name: Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor Condition:
|
Completed |
Study Name: Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma Condition:
|